wellrank.ai
Sign In
Aveed logo

Aveed

First cited by AI Jun 12, 2026
aveedme.com

Surfaced organically in AI answers about trt and men's health. Not yet profiled.

AI Visibility

Visibility trend

TRT and men's health, daily share of AI answers mentioning Aveed, through Jul 27, 2026.

5.0%

Avg position when mentioned: 6.7 · peak 12% on Jun 17

By engine

Where Aveed is strong, and where it is invisible.

  • ChatGPT
    20.0%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 2 positive mentions
  • 42 neutral
  • 4 mixed or cautious

Recent AI answers mentioning Aveed

ChatGPTJul 25, 2026, 12:36 UTC
Can I stop TRT once I start or is it forever?

Short answer: Yes — you can stop TRT, but whether your body returns to normal on its own and how long that takes is variable. It’s not necessarily “forever,” but some people need medical help to restart their own testosterone production. Key points to know Why TRT suppresses you: Exogenous testosterone lowers LH/FSH from the pituitary and suppresses testicular testosterone production and spermatogenesis. That suppression can persist after stopping. Recovery timeline: For many men the hypothalamic–pituitary–testicular (HPT) axis begins to recover within weeks to months; full recovery of testosterone can take several months. Sperm recovery (if suppressed) often takes 6–18 months and up to 2 years in some cases. Factors that make recovery slower or incomplete: older age, longer duration of TRT, higher doses, certain routes (long‑acting injections can cause prolonged suppression), and preexisting testicular dysfunction. Fertility: If you want children, don’t start standard TRT without discussing alternatives first — TRT commonly decreases or eliminates sperm production. Use fertility‑preserving options instead. Alternatives and treatments to restart/maintain function Human chorionic gonadotropin (hCG) (brands: Pregnyl, Novarel, Ovidrel) — mimics LH and stimulates the testes to make testosterone and sperm; commonly used to preserve or restore fertility. Clomiphene citrate (Clomid) — an oral selective estrogen‑receptor modulator that increases LH/FSH and can raise endogenous testosterone while preserving sperm. Aromatase inhibitors (off‑label in men) in select cases to raise testosterone by reducing estrogen conversion. If you’re on TRT and want to stop, your doctor may stop testosterone and start hCG and/or clomiphene to speed recovery, especially if fertility is a concern. Monitoring and follow‑up Get baseline/serial labs: morning total testosterone, free testosterone, LH, FSH, estradiol, hemoglobin/hematocrit, PSA (as indicated). For fertility concerns: semen analysis. Useful lab services: Quest Diagnostics or LabCorp for reliable local testing. Specialist care: see an endocrinologist or a reproductive urologist (male fertility specialist) for personalized planning. Practical next steps Don’t stop or change medication without talking to the clinician who prescribed it. They can plan testing and a transition strategy. If you hope to have children, tell your prescriber now — they can switch you to hCG/Clomid instead of standard TRT. If you’ve already been on TRT and want to stop, arrange labs and a specialist consult to decide whether watchful waiting or medical assistance to restart your axis is best. If you tell me your age, how long you’ve been on TRT, which formulation (topical gel like AndroGel/Testim, injections like Depo‑Testosterone or Aveed/Nebido, or pellets), and whether you want children, I can give more specific guidance.

Mentioned in position 10 of 11

Read full answer with sources →
ChatGPTJul 25, 2026, 12:36 UTC
How quickly does TRT work for energy and libido?

Short answer Libido: many men notice improvement within 2–6 weeks; most see a clear change by 3 months. Energy/fatigue: often slower — some feel better in 2–4 weeks, but more typical improvements occur by 8–12 weeks, with maximal benefit by ~3–6 months. Why the difference Libido is more directly sensitive to rising testosterone so it often responds earlier. Energy, mood, body composition and stamina depend on downstream changes (muscle, metabolism, sleep, mood) that take longer to develop. Erectile function may or may not improve with TRT alone because erections depend on blood flow, nerves and other hormones; many men still need a PDE5 inhibitor (sildenafil/avanfil/ tadalafil) for full effect. What affects how fast you feel better Baseline testosterone level and how low it was Age, weight, sleep, mood disorders, other health problems (diabetes, thyroid disease, anemia) TRT dose and formulation (injections cause peaks/troughs; gels/pellets give steadier levels) Adherence and correct application/dosing Formulation examples (brands) and practical differences Intramuscular injections: Depo‑Testosterone (testosterone cypionate) — common, inexpensive, given every 1–2 weeks; Aveed (testosterone undecanoate) — long‑acting (months between injections). Injections can produce quicker rises but sometimes mood swings with peaks/troughs. Topical gels: AndroGel, Testim — steady daily dosing, easier steady blood levels, no injection required (but watch skin transfer). Nasal: Natesto — short acting, dosed multiple times daily; good if you want rapid stop/start or avoid skin transfer. Pellets: Testopel — implanted subdermal pellets that release testosterone for several months; steady levels but requires minor procedure. Monitoring and safety Baseline and periodic labs: total testosterone, hematocrit, PSA, liver function and lipids; check levels 2–12 weeks after start/change and then every 3–6 months. TRT suppresses sperm production — discuss alternatives (hCG, clomiphene) if you want fertility. Possible side effects: increased hematocrit, acne, fluid retention, mood changes; rare risks should be discussed with your clinician. When to reassess If you have no meaningful improvement in libido or energy after about 3 months (and levels are in target range), reassess for other causes and treatment adjustments. If you have worsening symptoms or side effects, contact your prescriber sooner. Where to get evaluated/treated (examples) For convenience/telemedicine: Hims, Roman (Ro), Vault Health — they offer testing and TRT via telehealth and are useful for straightforward cases. For complex cases or fertility concerns: see a urologist or endocrinologist in person — they can do more detailed evaluation and individualized plans. If you want, tell me what formulation you’re considering (injection, gel, pellet, nasal), your age, baseline testosterone level, and whether you want future fertility — I can give a more tailored timeline and monitoring checklist.

Mentioned in position 2 of 9

Read full answer with sources →
ChatGPTJul 24, 2026, 09:36 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer: start by clarifying your goals and lab pattern. If you want to preserve (or improve) fertility and you have secondary/central hypogonadism, try a gonadotropin-stimulating approach (enclomiphene or, more commonly, clomiphene) first. If you have primary testicular failure, are older and don’t want fertility, or need fast, predictable symptom control, consider testosterone replacement therapy (TRT). Key points to help decide Goal: fertility vs symptom relief Fertility desired: avoid standard TRT because it suppresses LH/FSH and sperm production. Enclomiphene (or clomiphene) stimulates the HPT axis and is the preferred first option. Fertility not desired and you want reliable symptom control (energy, libido, muscle mass): TRT is often preferred. Cause of low T (lab pattern) Secondary/central hypogonadism: low T with low/normal LH and FSH → a SERM (enclomiphene/clomiphene) or hCG may restore endogenous testosterone and preserve sperm. Good first-line choice. Primary hypogonadism: low T with high LH/FSH → testes likely won’t respond; TRT is usually the right choice. Age and comorbidities Younger men and men trying to father kids: favor HPT-stimulating therapy first. Older men, men with markedly low testosterone and severe symptoms, or those with irreversible testicular failure: TRT is reasonable. Availability and evidence Enclomiphene (brand name Androxal) has been studied for male hypogonadism but is not widely available/approved everywhere. Clomiphene citrate (Clomid) is commonly used off-label and has a long track record. TRT formulations are well established, widely available, and FDA-approved. Safety/monitoring differences Enclomiphene/clomiphene: may cause mood changes, visual symptoms in rare cases; requires monitoring of testosterone and sometimes LH/FSH and estradiol. Generally preserves or improves sperm count. TRT: can improve symptoms reliably but suppresses spermatogenesis, can raise hematocrit, affect lipids, and needs PSA/hematocrit monitoring and periodic testosterone checks. Practical options (brands/services) If considering enclomiphene/clomiphene: Clomiphene citrate (Clomid) — widely used off-label for men; familiar to many clinicians and easier to obtain. Enclomiphene (Androxal) — studied specifically for men but availability/approval varies by country. If considering TRT: Gels: AndroGel, Testim — daily application, convenient but risk of transfer to others. Patches: Androderm — daily patch option. Injections: Depo-Testosterone (testosterone cypionate), Delatestryl/testosterone enanthate — common, cost-effective IM injections. Long-acting IM: Aveed (testosterone undecanoate) / Nebido (outside US) for less frequent dosing. Pellets: Testopel — implanted pellets that last months. Telemedicine/clinic services (for consultation, labs, prescriptions, monitoring): Vault Health, Defy Medical — focused on men’s hormone care and specialist-driven monitoring. Roman, Hims — consumer-friendly telehealth options (more convenient but choose one that provides proper labs and specialty follow-up). For fertility concerns, see a reproductive endocrinologist or urologist/andrologist. What to do next Get baseline labs (morning total testosterone — 8–10 AM on at least two occasions — plus LH, FSH, prolactin, estradiol, SHBG as indicated; CBC, CMP, lipid panel, PSA if older). Share results with an endocrinologist, urologist, or a reputable men’s-health clinic (Vault, Defy, or a local specialist) to choose the right therapy. If fertility is a priority and labs show secondary hypogonadism, discuss clomiphene/enclomiphene or hCG first. If primary hypogonadism or severe symptoms and no desire for fertility, discuss TRT options and monitoring. If you’d like, tell me your age, whether you want children, and any lab results or symptoms — I can help interpret them and suggest a practical next step.

Mentioned in position 8 of 14

Read full answer with sources →
ChatGPTJul 22, 2026, 09:37 UTC
What are the risks and side effects of starting TRT in your 30s?

Short answer Starting testosterone replacement therapy (TRT) in your 30s can help if you have true hypogonadism, but it carries several important risks — most notably suppression of fertility, testicular shrinkage, blood changes (polycythemia), possible cardiovascular effects, and other hormone-related side effects. Because you’re in your 30s, fertility and long‑term risks are often the deciding factors and need careful discussion with a clinician before starting. Main risks and side effects Fertility suppression and testicular atrophy Exogenous testosterone suppresses the hypothalamic–pituitary–gonadal (HPG) axis (↓ LH/FSH), often causing decreased sperm production or even temporary azoospermia. Testes may shrink. Recovery can take months to years and is not always complete. This is the biggest concern for men who want biological children. Erythrocytosis / polycythemia TRT can raise red blood cell mass (hematocrit). High hematocrit increases risk of blood clots, stroke, or heart attack if not monitored and managed. Cardiovascular risk Data are mixed. Some studies suggest increased risk of cardiovascular events in men with preexisting heart disease; the risk in younger otherwise healthy men is less clear but should be considered, especially if you have risk factors (smoking, hypertension, high cholesterol, obesity). Gynecomastia, acne, hair loss Testosterone can convert to estrogen (aromatization), causing breast tissue growth or tenderness. Acne and acceleration of male‑pattern baldness can occur. Mood and behavior Some men experience mood swings, irritability, or increased aggression; others report mood improvement. Monitor closely. Sleep apnea TRT can worsen or unmask obstructive sleep apnea in susceptible men. Prostate effects TRT can raise PSA and may worsen lower urinary tract symptoms (BPH). Active prostate or breast cancer is a contraindication. Liver effects Oral 17‑alkylated androgens can cause liver toxicity; injectable and topical formulations have minimal direct liver toxicity but liver tests are monitored. Skin irritation and transfer Topical gels/solutions can irritate skin and can be unintentionally transferred to partners/children if precautions aren’t followed. Injection‑related issues Pain, local irritation, rare oil‑embolism risk with certain long‑acting formulations. Baseline tests and monitoring (typical) Before starting: two morning total testosterone measurements, LH/FSH, prolactin if low T, CBC (hematocrit), PSA (age‑dependent), fasting glucose/HbA1c, lipid panel, liver enzymes. Ongoing: testosterone level ~4–12 weeks after starting/dose change, then every 3–6 months initially; CBC every 3–6 months first year then annually; PSA annually (or per urologist), lipids and metabolic labs annually. If hematocrit >54% or other concerning results, TRT should be paused/adjusted and managed. Fertility-preserving alternatives and options If you want kids, discuss alternatives before starting: Clomiphene citrate (Clomid) — an oral SERM that stimulates endogenous LH/FSH and can raise testosterone while preserving fertility in many men. Human chorionic gonadotropin (hCG) — preserves intratesticular testosterone and spermatogenesis; often used with or instead of TRT for men desiring fertility. Aromatase inhibitors (anastrozole) in select cases to manage estrogen conversion. Sperm banking (cryopreservation) before starting TRT is a prudent option if you may want biological children. These options should be managed by a urologist or reproductive endocrinologist. Formulation differences (pros/cons) and example brands Topical gels: AndroGel, Testim, Fortesta Pros: steady daily dosing, easy to stop; cons: skin transfer risk, daily application. Patches: Androderm Pros: steady levels; cons: skin irritation, adhesive issues. Short‑acting injectables: Depo‑Testosterone (testosterone cypionate), Testosterone enanthate Pros: inexpensive, widely used; cons: peaks/troughs (can cause mood/energy swings). Long‑acting injectable: Aveed (testosterone undecanoate) / Nebido (brand outside US) Pros: infrequent dosing (10–12 weeks); cons: risk of pulmonary oil microembolism (Aveed requires REMS in the US), injection-site reactions. Buccal: Striant Pros: avoids transference; cons: local gum irritation. Pick a formulation based on lifestyle, monitoring, and side effect profile; discuss with your prescriber. Where to get care / services (options) See a urologist or endocrinologist for comprehensive evaluation and fertility counseling (best for nuanced care). If you prefer telehealth, services such as Hims or Roman can be convenient for access to TRT, but they may not provide the full in‑person workup (make sure they do baseline labs and fertility counseling). For fertility preservation or assistance, use a local fertility clinic or national sperm banks (for example, Cryos International) to discuss sperm banking. What to discuss with your doctor Confirmed low testosterone on repeat morning tests and whether symptoms match. Fertility plans — want children soon or later? Baseline cardiometabolic risk and family/personal cancer history. Which TRT formulation fits your life and the monitoring plan. Alternatives to TRT (clomiphene, hCG) if fertility preservation is a priority. Plan for monitoring labs and dose adjustments. Bottom line TRT can improve symptoms in men with true hypogonadism, but in your 30s the most important risks are suppressed fertility and potential long‑term cardiovascular and hematologic effects. Before starting, get a full evaluation (repeat morning testosterone, LH/FSH, CBC, metabolic panel), discuss fertility preservation (or use alternatives like clomiphene/hCG), and plan close laboratory monitoring with a urologist or endocrinologist. If you’d like, tell me whether you’re concerned about fertility, what symptoms you have, and whether you prefer injections or topical therapy — I can give more tailored information.

Mentioned in position 7 of 12

Read full answer with sources →
ChatGPTJul 20, 2026, 09:35 UTC
How quickly does TRT work for energy and libido?

Short answer Libido (sexual desire) often improves first — many men notice changes within days to a few weeks, commonly by 2–6 weeks. Energy and persistent reductions in fatigue usually take longer — expect gradual improvement over 4–12 weeks, with the biggest change often by 3 months (some men need 6 months for full benefit). What determines how fast you’ll feel better Baseline testosterone level and severity of symptoms — lower starting T often gives a clearer response. Cause of symptoms — if fatigue or low libido are mainly from sleep apnea, depression, medications, or thyroid problems, TRT alone may not fix them. Formulation and dosing — different delivery methods reach steady blood levels at different speeds. Age, overall health, and other conditions (anemia, diabetes, obesity, mood disorders) also affect response. How formulations compare (brands/examples and why they matter) Short-acting intramuscular injections (testosterone cypionate, enanthate — commonly given as generic or Depo-Testosterone in some markets): work quickly and raise levels within days; dosing every 1–2 weeks can cause peaks and troughs that influence symptom timing. Long-acting intramuscular (testosterone undecanoate — Aveed, Nebido): steadier levels over months; may take longer to reach full effect but fewer injections. Topical gels (AndroGel, Testim, Fortesta, Axiron): steady daily dosing; blood levels generally stabilize in 2–4 weeks, and many men notice libido changes early and energy changes over weeks. Patches (Androderm): steady delivery, similar timeline to gels. Subcutaneous pellets (Testopel): continuous release over months; symptom changes may be gradual. Monitoring and what to expect clinically Labs: clinicians usually check morning total testosterone 2–8 weeks after starting or changing dose (timing depends on formulation), then every 3–6 months while stable. Also monitor hematocrit, PSA, lipids, liver tests as indicated. If you’re on injectable cypionate/enanthate, providers often check trough levels (just before next shot) to adjust dosing. For undecanoate, levels and symptoms are checked at ~3 months. If you don’t improve Recheck testosterone levels to confirm adequate dosing/absorption. Look for other causes (depression, sleep apnea, thyroid disease, medication side effects, low libido not related to T). Consider switching formulation or adjusting dose. Erectile function may lag behind libido; PDE5 inhibitors (sildenafil/Viagra, tadalafil/Cialis) are commonly added if needed. Safety and fertility notes TRT can suppress sperm production — if you want future fertility, discuss alternatives before starting (clomiphene citrate, hCG injections, or sperm banking). hCG brands and clomiphene are used off-label to preserve/testosterone production in testes. Common things to monitor: hematocrit (risk of polycythemia), prostate symptoms and PSA, mood changes. Contraindications include active prostate or breast cancer. Practical next steps Expect early libido improvement (weeks) and slower energy gains (weeks–months). Keep close follow-up with your prescriber for symptom checks and labs at ~6–12 weeks after starting, then periodically. If you don’t feel better after a reasonable period (8–12 weeks) and labs show adequate T, ask your clinician to investigate other causes or try a different regimen. If you want, tell me: Which formulation you’re considering or already using, and how long you’ve been on it — I can give more tailored timing and monitoring guidance.

Mentioned in position 2 of 9

Read full answer with sources →
ChatGPTJul 19, 2026, 12:17 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer If you want to preserve or restore fertility, or if your low testosterone is due to a “secondary” problem (low/normal LH/FSH), try a drug that stimulates your own hormones first (eg, enclomiphene or more commonly clomiphene ± hCG). If you have primary hypogonadism (high LH/FSH), or you need predictable symptom control and don’t care about fertility, testosterone replacement therapy (TRT) is usually the logical choice. Why (concise comparison) Mechanism Enclomiphene/clomiphene (SERMs): raise GnRH→LH/FSH→increase endogenous testosterone and preserve/testicular function and sperm production. TRT (exogenous testosterone): raises serum testosterone directly but suppresses LH/FSH and usually lowers sperm count and testicular size. Fertility Enclomiphene/clomiphene or hCG preserve or can improve fertility. TRT usually decreases fertility; avoid if you want to father children. Onset and symptom control TRT usually gives more reliable and often faster symptom relief. SERMs can take weeks to months and response is more variable. Suitability by cause Secondary hypogonadism (pituitary/hypothalamic): SERMs/hCG often work well. Primary testicular failure: TRT is usually required. Side effects and monitoring TRT: erythrocytosis, possible PSA/prostate effects, skin irritation (gels), injection-site issues; monitor hematocrit, testosterone, PSA. SERMs: mood changes, visual symptoms (rare), possible hot flashes; monitor testosterone, LH/FSH, estradiol, sperm if fertility is a concern. Availability and cost Clomiphene (Clomid/generic) is widely available off‑label and inexpensive. Enclomiphene (Androxal) has had limited/varied regulatory availability and may be harder to obtain. TRT options include gels (AndroGel, Testim, Axiron, Fortesta), injections (Depo-Testosterone — cypionate/enanthate, Aveed — long‑acting undecanoate), patches (Androderm), and pellets (Testopel). When to consider which first (practical steps) Get proper testing first (morning labs): total testosterone (repeat), free testosterone, LH, FSH, prolactin, and if appropriate PSA and basic metabolic panel. If tests show secondary hypogonadism (low testosterone with low/normal LH/FSH) and you want fertility: consider clomiphene (Clomid/generic) or enclomiphene where available; hCG (Pregnyl, Ovidrel or other products) is another fertility-preserving option. If tests show primary hypogonadism (low T with high LH/FSH) or severe symptoms where fast, predictable relief is the priority and fertility is not desired: consider TRT (brands above). If fertility may be needed but you still want symptomatic relief, discuss combination strategies (eg, low‑dose TRT plus hCG, or intermittent therapy) with a specialist. Brands/services to know (examples) SERMs/fertility-preserving: Clomid (clomiphene citrate, generic), Androxal (enclomiphene — limited availability); consider hCG brands like Pregnyl or recombinant Ovidrel for fertility support. TRT: AndroGel, Testim, Axiron, Fortesta (gels); Depo‑Testosterone (testosterone cypionate/enanthate injections); Aveed (testosterone undecanoate long‑acting IM); Androderm (patch); Testopel (pellets). Clinics/labs: see an endocrinologist or reproductive urologist for individualized care. For convenience/ongoing TRT management some use men’s health telemedicine services (eg, Roman, Hims, Vault) but specialist care is better if fertility or complex issues are present. Use LabCorp or Quest for blood work. Safety and follow-up Don’t start either therapy without medical evaluation and baseline labs. Expect follow-up labs: testosterone and hematocrit at 6–12 weeks after starting TRT; for SERMs check testosterone, LH/FSH and sperm analysis per your fertility goals. Discuss prostate cancer risk, cardiovascular history, sleep apnea, and thrombotic risk with your clinician. Bottom line If fertility or restoring your own hormone axis matters, try a fertility‑preserving approach (enclomiphene/clomiphene ± hCG) first. If you have primary testicular failure or want fast, reliable symptom relief and aren’t concerned about fertility, TRT is usually the appropriate first-line therapy. Talk with an endocrinologist or reproductive urologist, bring morning testosterone + LH/FSH results, and decide together which path fits your goals. If you want, tell me your recent morning testosterone and LH/FSH results and whether you want children — I can give more tailored guidance.

Mentioned in position 7 of 17

Read full answer with sources →

TL;DR

Aveed is a prescription testosterone undecanoate injection developed by Endo Pharmaceuticals and indicated for men with hypogonadism. It is administered in a clinical setting rather than at home, distinguishing it from many consumer-facing testosterone therapies. In WellRank's latest index it ranks tenth in TRT and men's health with 8% AI visibility, appearing in 5 mentions that are entirely neutral in tone, suggesting it is cited as a clinical reference point rather than a recommended destination.

Company Overview

Aveed is an FDA-approved branded pharmaceutical product manufactured and marketed by Endo Pharmaceuticals, a specialty pharmaceutical company. The product is available only through a restricted Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of serious pulmonary oil microembolism and anaphylaxis following injection. The business model centers on prescription sales through certified healthcare provider offices rather than direct-to-consumer channels. More information about the product and its requirements is available at aveedme.com.

Product Features

  • Long-acting testosterone undecanoate injection (750 mg/3 mL) for intramuscular use
  • Extended dosing schedule requiring injections roughly every 10 weeks after an initial loading period
  • Administration restricted to certified healthcare settings under the Aveed REMS program
  • Indicated specifically for adult males diagnosed with primary or hypogonadotropic hypogonadism
  • Available as a single-dose vial dispensed directly to the administering healthcare provider

Target Market

Aveed targets adult men diagnosed with hypogonadism, either primary or hypogonadotropic in origin, who are managed by endocrinologists, urologists, or other licensed healthcare providers. It is approved and marketed in the United States and is not designed for self-administration, so its practical audience is men who are already engaged with clinical care. It does not address other conditions beyond testosterone deficiency.

Buyer Personas

  • An adult man in his 40s or 50s diagnosed with low testosterone by an endocrinologist who prefers infrequent clinic visits over daily or weekly self-administration.
  • A urologist or men's health specialist seeking a long-acting injectable option for patients who cannot reliably self-administer topical or short-acting therapies.
  • A patient who has tried topical androgens such as AndroGel and wants a longer dosing interval with consistent serum testosterone levels.
  • A health insurer or pharmacy benefits manager evaluating formulary placement for long-acting injectable testosterone therapies.

Funding & Performance

Aveed is a branded prescription product of Endo Pharmaceuticals, which has been a publicly traded and subsequently restructured company; the specific financial performance attributable to Aveed alone is not publicly disclosed as a separate line item.

Recent Developments

Aveed has maintained its FDA-approved indication and REMS program requirements since its original approval, with no widely reported reformulation or expanded indication. Endo Pharmaceuticals has undergone significant corporate restructuring in recent years, though the impact on Aveed's commercial operations has not been separately detailed in widely available sources. The product continues to be positioned as a long-acting clinical alternative within the broader testosterone replacement therapy category.

Competitive Landscape

In WellRank's co-mention data, Aveed appears alongside Testim, Depo-Testosterone, AndroGel, Testopel, and Natesto as prescription testosterone products, reflecting its position among branded and generic clinical therapies. It also surfaces near direct-to-consumer telehealth platforms such as Roman and Hims, which indicates AI engines are grouping it within broader TRT conversations even though its clinic-only model differs sharply from those services. Clomid's presence in co-mentions suggests AI engines sometimes address the full spectrum of hormone optimization options in the same answers.

Aveed vs the brands AI recommends alongside it

The real competitive set in TRT and men's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Aveed logo
AveedThis brand
#28
5.0%
AndroGel logo
AndroGel

46 shared answers

#5
18.3%
Testim logo
Testim

45 shared answers

#6
18.3%
Depo-Testosterone logo
Depo-Testosterone

40 shared answers

#12
13.3%
Roman logo
Roman

34 shared answers

#3
23.3%

Email me when overtakes Aveed

One email the day the ranks flip. Nothing else.

User Sentiment

According to WellRank's corpus of five AI mentions, all are neutral and none are positive or cautious, meaning AI engines present Aveed in a factual, informational manner consistent with clinical reference material rather than endorsement or concern. Public discussion tends to reflect the product's technical profile, centering on its REMS requirements, injection schedule, and prescription-only status rather than consumer experience. This neutral tone is typical for pharmaceutical brands that operate outside direct-to-consumer marketing.

Pricing

Aveed is a prescription pharmaceutical product; pricing varies by healthcare provider, insurance coverage, and pharmacy or specialty distributor and is not published as a standard consumer-facing figure.

Sources cited around Aveed

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Aveed weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Aveed? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.